Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Hopes for new cell therapies ‘stem’ from Sheffield

09.07.2004


The Centre for Stem Cell Biology (CSCB) at the University of Sheffield is welcoming some of the world’s leading experts to its International Human Embryonic Stem Cell Symposium on Friday 9 July 2004. The CSCB is a world-leading centre for stem cell research, and has produced two of the UK’s six embryonic stem cell lines. The symposium will allow around 200 scientists to benefit from the experience of the world’s leading researchers in this area.



Embryonic stem cell technology is a new area of science and has the potential to offer cures for degenerative conditions such as multiple sclerosis and Parkinson’s disease. Researchers at the University of Sheffield are working on developing stem cell technology to cure type 1 diabetes, by developing pancreas islet cells, which are responsible for producing insulin. Patients with this disease lose their islet cells to autoimmune disease. It is hoped that islet cells produced from embryonic stem cells can be used for cell replacement therapies.

Earlier in the week the CSCB hosted the second Practical Training Course in handling human embryonic stem cells. That course, conducted in conjunction with the UK Stem Cell Bank, and sponsored by the MRC, BBSRC and the Department of Health, aimed to introduce a group of 16 researchers to the techniques required for working with these cells.


Professor Peter Andrews of the University of Sheffield is also co-ordinating the International Stem Cell Initiative, under the auspices of the International Stem Cell Forum, an organisation of the medical funding agencies from 14 countries worldwide. The Initiative will seek to evaluate all of the embryonic stem cell lines in the world (over 70 in total) in order to develop a worldwide standard fo ridentifying and defining these important cells.

Professor Harry Moore, who, with Professor Andrews, co-directs the Centre for Stem Cell Biology at the University of Sheffield explains, “Embryonic stem cells are special because they are able to differentiate and potentially become any cell in the body. The science is fairly new but harnessing their abilities could allow us to develop therapies for a wide range of degenerative conditions.

“The Centre for Stem Cell Biology is focussing on producing embryonic stem cells that have been produced under strict regulations, ensuring that they could be used for clinical cell therapy in the future. The symposium will allow us to discuss with other researchers the current state of knowledge of these amazing cells and provide a stepping stone towards their eventual use in human healthcare.”

Lorna Branton | alfa
Further information:
http://www.shef.ac.uk

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>